Serialization/Anti-Counterfeiting for Several Leading Pharmaceutical Manufacturers
Project Snapshot
Counterfeit drugs are a real danger to customers’ health. As falsified medicines become more sophisticated, the risk of them reaching patients increases. For that reason, government agencies around the world have implemented regulations with which pharmaceutical industry players have to comply.
Serialization and aggregation contribute to building end-to-end traceability in order to secure the global supply chain.
Sterling provided capital program management solutions for several pharmaceutical companies. We created teams including mechanical, controls, vision, validation, and packaging engineers. Our team supported projects worldwide to meet U.S., Asia, and EU serialization requirements. Lines were integrated with serialization hardware and software in Germany, Italy, Puerto Rico, and several locations in the United States.
- A majority of the pharmaceutical global packaging lines had to be retrofitted simultaneously to meet the deadline.
- Each pharmaceutical company had a large-scale project to meet these requirements, impacting the availability of limited resources with the required expertise.
- Hardware and software were being developed throughout the integration phrase, due to new technology and tight deadline constraints.
Sterling's Solution
Established global teams of integration engineers to address a significant number of line upgrades in a very limited timeframe.
